Assenagon Asset Management »

Aclaris Therapeutics shares owned by Assenagon Asset Management

Quarter-by-quarter ownership of Aclaris Therapeutics (ACRS) shares owned by Assenagon Asset Management from 13F filings

Historical chart of Assenagon Asset Management investment in Aclaris Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aclaris Therapeutics held by Assenagon Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aclaris Therapeutics by Assenagon Asset Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $465k 155k 3.01
2025-09-30 $294k 155k 1.90
2025-06-30 $262k 185k 1.42
2025-03-31 $1.0M 682k 1.53
2024-12-31 $986k 397k 2.48
2024-09-30 $214k 186k 1.15
2023-09-30 $4.7M 687k 6.85
2023-06-30 $6.6M 637k 10.37
2023-03-31 $3.4M 426k 8.09
2022-12-31 $3.1M 195k 15.75
2022-09-30 $3.1M 195k 15.74
2022-06-30 $4.1M 293k 13.96
2022-03-31 $8.7M 507k 17.24
2021-09-30 $8.5M 473k 18.00
2021-06-30 $10M 577k 17.56
2021-03-31 $519k 21k 25.21
2019-06-30 $182k 83k 2.20
2018-12-31 $894k 121k 7.39